Loading...
Keywords
Last Name
Institution

Joy Fulbright

Concepts (145)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
7
2020
87
2.480
Why?
Rabies Vaccines
2
2016
4
1.330
Why?
Purpura, Thrombocytopenic, Idiopathic
2
2016
7
1.330
Why?
Heart
2
2016
13
1.180
Why?
Anthracyclines
3
2016
5
1.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2019
33
1.140
Why?
Antineoplastic Agents
3
2019
44
1.080
Why?
Health Plan Implementation
2
2020
11
1.060
Why?
Medical Oncology
2
2020
16
1.050
Why?
Primary Health Care
2
2020
36
1.030
Why?
Heart Diseases
3
2015
11
0.900
Why?
Specialization
1
2020
9
0.900
Why?
Leukemia, Myeloid, Acute
2
2011
90
0.890
Why?
Health Personnel
1
2020
26
0.870
Why?
Humans
19
2021
5654
0.860
Why?
Apoptosis
2
2018
57
0.840
Why?
Drug Screening Assays, Antitumor
1
2018
3
0.780
Why?
Drug Repositioning
1
2018
4
0.780
Why?
Male
12
2021
3212
0.710
Why?
Echocardiography, Three-Dimensional
1
2016
25
0.700
Why?
Magnetic Resonance Imaging
1
2016
72
0.680
Why?
Cardiotonic Agents
1
2015
5
0.660
Why?
Acetylcysteine
1
2015
12
0.660
Why?
Adolescent
9
2021
1852
0.620
Why?
Cardiovascular Diseases
1
2015
36
0.610
Why?
Child
8
2020
2466
0.530
Why?
Xanthogranuloma, Juvenile
1
2012
1
0.530
Why?
Brain Neoplasms
1
2012
17
0.520
Why?
Drug-Related Side Effects and Adverse Reactions
1
2010
24
0.450
Why?
Survivors
4
2016
15
0.420
Why?
Cell Line, Tumor
2
2018
53
0.360
Why?
Heart Failure
2
2020
12
0.350
Why?
Troponin I
2
2016
3
0.340
Why?
Biomarkers
2
2016
117
0.320
Why?
Female
6
2020
3292
0.310
Why?
Animals
2
2018
866
0.300
Why?
Granular Cell Tumor
1
2021
1
0.240
Why?
Lower Extremity
1
2021
8
0.240
Why?
Child, Preschool
2
2016
1443
0.240
Why?
Learning
1
2020
8
0.230
Why?
Educational Status
1
2020
15
0.230
Why?
Lymphoma, T-Cell
1
2019
3
0.220
Why?
Asparaginase
1
2019
8
0.220
Why?
Polyethylene Glycols
1
2019
13
0.220
Why?
Desensitization, Immunologic
1
2019
16
0.220
Why?
Echocardiography
2
2020
55
0.210
Why?
Practice Patterns, Physicians'
1
2020
89
0.210
Why?
Drug Synergism
1
2018
5
0.200
Why?
High-Throughput Screening Assays
1
2018
5
0.200
Why?
Small Molecule Libraries
1
2018
5
0.200
Why?
Pelvic Neoplasms
1
2018
3
0.200
Why?
Organs at Risk
1
2018
3
0.200
Why?
Xenograft Model Antitumor Assays
1
2018
17
0.200
Why?
Cell Survival
1
2018
20
0.200
Why?
Dogs
1
2018
38
0.200
Why?
Fertility Preservation
1
2018
6
0.190
Why?
Osteosarcoma
1
2018
26
0.190
Why?
Adult
4
2020
1065
0.190
Why?
Bone Neoplasms
1
2018
22
0.190
Why?
Cell Proliferation
1
2018
58
0.190
Why?
Disease Models, Animal
1
2018
76
0.190
Why?
Dose-Response Relationship, Drug
1
2018
105
0.190
Why?
Counseling
1
2018
64
0.180
Why?
Treatment Outcome
3
2021
586
0.180
Why?
Natriuretic Peptide, Brain
1
2016
5
0.180
Why?
Peptide Fragments
1
2016
16
0.180
Why?
Feasibility Studies
1
2016
42
0.180
Why?
Risk Factors
3
2016
376
0.180
Why?
Mice
1
2018
410
0.180
Why?
Cardiotoxicity
1
2016
2
0.170
Why?
Cardiomyopathies
1
2016
4
0.170
Why?
Myocytes, Cardiac
1
2015
1
0.170
Why?
Jurkat Cells
1
2015
5
0.170
Why?
Reactive Oxygen Species
1
2015
7
0.170
Why?
Mice, SCID
1
2015
11
0.170
Why?
Leukocytes, Mononuclear
1
2015
7
0.170
Why?
Mice, Inbred BALB C
1
2015
29
0.170
Why?
Leukemia
1
2015
12
0.170
Why?
Oxidation-Reduction
1
2015
28
0.170
Why?
Antioxidants
1
2015
9
0.170
Why?
Oxidative Stress
1
2015
21
0.160
Why?
Acute Disease
1
2015
59
0.160
Why?
Cell Line
1
2015
106
0.160
Why?
Ambulatory Care Facilities
1
2015
25
0.160
Why?
Rats
1
2015
213
0.160
Why?
Porphyrins
1
2015
1
0.160
Why?
Dermatitis, Phototoxic
1
2015
1
0.160
Why?
Troponin T
1
2015
1
0.160
Why?
Phototherapy
1
2015
2
0.160
Why?
Delivery of Health Care
1
2015
27
0.160
Why?
Benzazepines
1
2015
6
0.160
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2015
13
0.160
Why?
Guidelines as Topic
1
2015
19
0.160
Why?
Humanism
1
2014
3
0.150
Why?
Hematology
1
2014
5
0.150
Why?
Professionalism
1
2014
3
0.150
Why?
Education, Medical, Graduate
1
2014
12
0.150
Why?
Radiotherapy, Adjuvant
1
2012
2
0.130
Why?
Infant
1
2016
1315
0.130
Why?
Central Nervous System Neoplasms
1
2011
2
0.130
Why?
Endocrine System Diseases
1
2011
2
0.120
Why?
Fertility
1
2011
16
0.120
Why?
Growth Disorders
1
2011
22
0.120
Why?
Stress, Psychological
1
2011
42
0.120
Why?
Iron Chelating Agents
1
2010
1
0.120
Why?
Razoxane
1
2010
1
0.120
Why?
Delayed-Action Preparations
1
2010
5
0.120
Why?
Drug Carriers
1
2010
2
0.120
Why?
Doxorubicin
1
2010
16
0.120
Why?
Drug Dosage Calculations
1
2010
18
0.120
Why?
Disease Progression
1
2010
71
0.120
Why?
Drug Administration Schedule
1
2010
50
0.110
Why?
Obesity
1
2011
91
0.110
Why?
Randomized Controlled Trials as Topic
1
2010
82
0.110
Why?
Young Adult
2
2020
526
0.090
Why?
Pediatrics
2
2016
218
0.060
Why?
Biopsy
1
2021
52
0.060
Why?
Models, Cardiovascular
1
2020
4
0.060
Why?
Cost-Benefit Analysis
1
2020
40
0.060
Why?
Aged, 80 and over
1
2020
114
0.060
Why?
Practice Guidelines as Topic
1
2020
102
0.050
Why?
Quality of Life
1
2020
97
0.050
Why?
Aged
1
2020
292
0.050
Why?
Prognosis
1
2019
182
0.050
Why?
Middle Aged
1
2020
561
0.050
Why?
Primary Ovarian Insufficiency
1
2018
3
0.050
Why?
Puberty
1
2018
6
0.050
Why?
Missouri
1
2018
80
0.050
Why?
Radiotherapy
1
2016
4
0.040
Why?
Continuity of Patient Care
1
2015
7
0.040
Why?
Program Development
1
2015
18
0.040
Why?
Needs Assessment
1
2015
28
0.040
Why?
Program Evaluation
1
2015
48
0.040
Why?
Erythroblastosis, Fetal
1
2015
2
0.040
Why?
Erythrocyte Transfusion
1
2015
3
0.040
Why?
Hyperbilirubinemia
1
2015
8
0.040
Why?
Emergencies
1
2014
13
0.040
Why?
Diagnosis, Differential
1
2014
69
0.040
Why?
Curriculum
1
2014
21
0.040
Why?
Age Factors
1
2015
227
0.040
Why?
Retrospective Studies
1
2018
953
0.040
Why?
Attitude of Health Personnel
1
2014
89
0.040
Why?
Surveys and Questionnaires
1
2014
266
0.030
Why?
United States
1
2015
657
0.030
Why?
Infant, Newborn
1
2015
933
0.030
Why?
Fulbright's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_